CTI Science
Stage
AcquiredTotal Raised
$5.07MPortfolio Exits
1Investments
1Funding, Valuation & Revenue
4 Fundings
CTI Science's latest funding round was a Unattributed - III for $0.27M on January 16, 2014.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
1/16/2014 | Unattributed - III | $0.27M | Undisclosed Investors | 1 | ||
10/31/2013 | Angel | |||||
10/27/2008 | Unattributed - II | |||||
4/2/2008 | Unattributed |
Date | 1/16/2014 | 10/31/2013 | 10/27/2008 | 4/2/2008 |
|---|---|---|---|---|
Round | Unattributed - III | Angel | Unattributed - II | Unattributed |
Amount | $0.27M | |||
Investors | Undisclosed Investors | |||
Valuation | ||||
Revenue | ||||
Sources | 1 |
This profile has not been claimed.
You're more than your latest funding, tell our customers your company's story.
CTI Science Investments
1 Investments
CTI Science has made 1 investments. Their latest investment was in TargeGen as part of their Series D on July 7, 2007.
CTI Science Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
7/11/2007 | Series D | TargeGen | $40M | Yes |
Date | 7/11/2007 |
|---|---|
Round | Series D |
Company | TargeGen |
Amount | $40M |
New? | Yes |
Co-Investors | |
Sources |
CTI Science Portfolio Exits
1 Portfolio Exit
CTI Science has 1 portfolio exit. Their latest portfolio exit was TargeGen on June 30, 2010.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.